Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr;33(4):662-664.
doi: 10.1681/ASN.2022020173.

The Search for the Perfect Agent for Anemia Management in Chronic Kidney Disease

Francesco Locatelli  1 , Lucia Del Vecchio  2
Affiliations
Editorial

The Search for the Perfect Agent for Anemia Management in Chronic Kidney Disease

Francesco Locatelli et al. J Am Soc Nephrol. 2022 Apr.
No abstract available

Keywords: HIF PH inihibitors; anemia; chronic kidney disease; dialysis; erythropoiesis stimulating agents; erythropoietin; roxadustat.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Roxadustat use in the dialysis-dependent population. Single boxes represent possible benefits, room for further investigation, and possible safety signals.
See this image and copyright information in PMC

Comment on

References

    1. Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell 148: 399–408, 2012 - PMC - PubMed
    1. Fishbane S, Pollock CA, El-Shahawy M, Escudero ET, Rastogi A, Pham Van B, et al. : Roxadustat versus epoetin alfa for treating anemia in patients with CKD on dialysis: results from the randomized phase 3 ROCKIES study. Roxadustat versus epoetin alfa for treating anemia in patients with chronic kidney disease on dialysis: results from the randomized phase 3 ROCKIES study. J Am Soc Nephrol 33: 850–866, 2022 - PMC - PubMed
    1. FDA Roxadustat Briefing Document: Roxadustat; NDA 213805, Cardiovascular and Renal Drugs Advisory Committee Meeting, July 15, 2021. Available at: https://www.fda.gov/media/150728/download. Accessed January 17, 2022
    1. Gupta N, Zhao YY, Evans CE: The stimulation of thrombosis by hypoxia. Thromb Res 181: 77–83, 2019 - PubMed
    1. Barratt J, Sulowicz W, Schömig M, Esposito C, Reusch M, Young J, et al. : Efficacy and cardiovascular safety of roxadustat in dialysis-dependent chronic kidney disease: pooled analysis of four phase 3 studies. Adv Ther 38: 5345-5360, 2021 - PMC - PubMed